关注
Babak Oskooei
Babak Oskooei
PhD in Statistics, University College London
没有经过验证的电子邮件地址
标题
引用次数
引用次数
年份
Adaptive designs in clinical trials: why use them, and how to run and report them
P Pallmann, AW Bedding, B Choodari-Oskooei, M Dimairo, L Flight, ...
BMC medicine 16, 1-15, 2018
6322018
A simulation study of predictive ability measures in a survival model I: explained variation measures
B Choodari‐Oskooei, P Royston, MKB Parmar
Statistics in medicine 31 (23), 2627-2643, 2012
1182012
Review and evaluation of performance measures for survival prediction models in external validation settings
MS Rahman, G Ambler, B Choodari-Oskooei, RZ Omar
BMC medical research methodology 17, 1-15, 2017
1002017
Testing many treatments within a single protocol over 10 years at MRC Clinical Trials Unit at UCL: Multi-arm, multi-stage platform, umbrella and basket protocols
MKB Parmar, MR Sydes, FH Cafferty, B Choodari-Oskooei, RE Langley, ...
Clinical trials 14 (5), 451-461, 2017
792017
Designs for clinical trials with time-to-event outcomes based on stopping guidelines for lack of benefit
P Royston, FMS Barthel, MKB Parmar, B Choodari-Oskooei, V Isham
Trials 12, 1-18, 2011
692011
RAMPART: A phase III multi-arm multi-stage trial of adjuvant checkpoint inhibitors in patients with resected primary renal cell carcinoma (RCC) at high or intermediate risk of …
B Oza, E Frangou, B Smith, H Bryant, R Kaplan, B Choodari-Oskooei, ...
Contemporary Clinical Trials 108, 106482, 2021
452021
Proposals on Kaplan–Meier plots in medical research and a survey of stakeholder views: KMunicate
TP Morris, CI Jarvis, W Cragg, PPJ Phillips, B Choodari-Oskooei, ...
BMJ open 9 (9), e030215, 2019
452019
A simulation study of predictive ability measures in a survival model II: explained randomness and predictive accuracy
B Choodari‐Oskooei, P Royston, MKB Parmar
Statistics in Medicine 31 (23), 2644-2659, 2012
362012
Adding new experimental arms to randomised clinical trials: impact on error rates
B Choodari-Oskooei, DJ Bratton, MR Gannon, AM Meade, MR Sydes, ...
Clinical Trials 17 (3), 273-284, 2020
352020
Point estimation for adaptive trial designs I: A methodological review
DS Robertson, B Choodari‐Oskooei, M Dimairo, L Flight, P Pallmann, ...
Statistics in medicine 42 (2), 122-145, 2023
272023
Impact of lack-of-benefit stopping rules on treatment effect estimates of two-arm multi-stage (TAMS) trials with time to event outcome
B Choodari-Oskooei, MKB Parmar, P Royston, J Bowden
Trials 14, 1-15, 2013
272013
Assessing the impact of efficacy stopping rules on the error rates under the multi-arm multi-stage framework
A Blenkinsop, MKB Parmar, B Choodari-Oskooei
Clinical Trials 16 (2), 132-141, 2019
262019
Measuring the impact of methodological research: a framework and methods to identify evidence of impact
VC Brueton, CL Vale, B Choodari-Oskooei, R Jinks, JF Tierney
Trials 15, 1-7, 2014
252014
Colorectal cancer incidence, mortality and survival in South-east England between 1972 and 2001
MA Sanjoaquin, B Choodari-Oskooei, C Dolbear, V Putcha, A Sehgal, ...
European journal of cancer prevention 16 (1), 10-16, 2007
252007
Type I error rates of multi-arm multi-stage clinical trials: strong control and impact of intermediate outcomes
DJ Bratton, MKB Parmar, PPJ Phillips, B Choodari-Oskooei
Trials 17, 1-8, 2016
222016
Combined test versus logrank/Cox test in 50 randomised trials
P Royston, B Choodari-Oskooei, MKB Parmar, JK Rogers
Trials 20, 1-10, 2019
212019
A menu-driven facility for sample-size calculation in multiarm, multistage randomized controlled trials with time-to-event outcomes: Update
DJ Bratton, B Choodari-Oskooei, P Royston
The Stata Journal 15 (2), 350-368, 2015
202015
The epidemiology and treatment of mesothelioma in South East England 1985–2002
V Mak, E Davies, V Putcha, B Choodari-Oskooei, H Møller
Thorax 63 (2), 160-166, 2008
132008
Multiarm, multistage randomized controlled trials with stopping boundaries for efficacy and lack of benefit: An update to nstage
A Blenkinsop, B Choodari-Oskooei
The Stata Journal 19 (4), 782-802, 2019
102019
Point estimation for adaptive trial designs
DS Robertson, B Choodari-Oskooei, M Dimairo, L Flight, P Pallmann, ...
arXiv, 2021
92021
系统目前无法执行此操作,请稍后再试。
文章 1–20